Prelude Capital Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-35,549
| Closed | -$5.37M | – | 1841 |
|
|
2022
Q3 | $5.37M | Sell |
35,549
-15,812
| -31% | -$2.39M | 0.19% | 76 |
|
|
2022
Q2 | $7.48M | Buy |
+51,361
| New | +$7.48M | 0.21% | 45 |
|
|
2020
Q3 | – | Sell |
-2,128
| Closed | -$156K | – | 2112 |
|
|
2020
Q2 | $156K | Buy |
+2,128
| New | +$156K | 0.01% | 548 |
|
|
2020
Q1 | – | Sell |
-4,581
| Closed | -$249K | – | 1880 |
|
|
2019
Q4 | $249K | Buy |
4,581
+3,447
| +304% | +$187K | 0.01% | 487 |
|
|
2019
Q3 | $47K | Sell |
1,134
-15,735
| -93% | -$652K | ﹤0.01% | 773 |
|
|
2019
Q2 | $739K | Buy |
16,869
+8,266
| +96% | +$362K | 0.04% | 225 |
|
|
2019
Q1 | $443K | Buy |
+8,603
| New | +$443K | 0.03% | 306 |
|
|
2018
Q4 | – | Sell |
-211
| Closed | -$8K | – | 2010 |
|
|
2018
Q3 | $8K | Buy |
+211
| New | +$8K | ﹤0.01% | 1205 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 1883 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 1766 |
|